Comment From Breakthrough Breast Cancer On Possible New Genetic Testing Technique

Main Category: Breast Cancer
Also Included In: Genetics
Article Date: 18 Sep 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Dr Sarah Rawlings, Head of Policy & Involvement at Breakthrough Breast Cancer, says:

"Only around 5% of all breast cancer cases are due to inherited faults in known breast cancer genes such as BRCA1 and BRCA2. Genetic testing is currently only offered to women with a strong family history of the disease and is not relevant for the majority of women.

"Women tell us that it can be distressing to wait for the results of a genetic test. The development of new techniques that could speed up the process is extremely welcome, however, further investigation is needed to determine the accuracy of this technique before it could replace more conventional methods."

Breakthrough Breast Cancer